Investor meet intimation
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges that it will be meeting institutional investors at the Mirae Asset Conference scheduled for Friday, May 23, 2025, in an in-person format. The disclosure has been made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company has clarified that only publicly available information will be shared during these meetings and no unpublished price-sensitive information (UPSI) will be discussed. The filing was signed by Milind Talegaonkar, Company Secretary & Compliance Officer, on May 15, 2025.
This is a routine regulatory disclosure and is unlikely to have a direct impact on the stock price. Investors should watch for any incremental commentary or management cues that emerge from the conference interactions.